A highly sensitive immunotherapy biomarker, without the need for probe and non-invasive for CAR-T cell fitness It presents eFIT, a biomarker that measures CELL TEMPERATURE to evaluate CELL APTIDITY. By detecting high cell temperatures, known as ‘cell fever’, eFIT predicts the failure of cellular therapies using ‘febrile’ cells. Its universal applicability supports any cell therapy program, including CANCER CELL IMMUNOTERAPY. A highly motivated and skilled team will develop eFIT to save lives.share on FacebookTwitterLinkedinEmailreport an issue
